Catalyst Wire Dossier Catalyst Wire Dossier

GENOSS DES sirolimus-eluting stent

sirolimus · Genoss Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GENOSS DES sirolimus-eluting stent, covering 2025-10-06 to 2025-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)

See pricing